Mounjaro Jags: the Facts Behind Scotland's Favourite Nickname for Tirzepatide

The biggest myth: Mounjaro jags are just the same as other weight-loss jabs, rebranded

This is the misconception our prescribers hear most often, and it matters because it shapes whether someone understands what they're taking. Mounjaro (tirzepatide) is not another GLP-1 injection with a different label. It is a dual GIP and GLP-1 receptor agonist, meaning it binds two separate gut-hormone receptors involved in appetite regulation and blood-sugar control. Semaglutide-based injections work on GLP-1 alone. That second pathway (GIP) appears to amplify the appetite-suppression effect, which is part of why tirzepatide produced greater average weight loss than semaglutide 2.4 mg in the SURMOUNT-5 head-to-head trial, published in the New England Journal of Medicine in 2025.

The jag itself is delivered via a pre-filled KwikPen. Each pen holds four weekly doses; you use one dose per week, once every seven days, and inject just under the skin. The pen format means you do not draw up a syringe or measure anything. Injection sites are the abdomen, thigh or upper arm, and rotating them each week reduces localised reactions. For a fuller look at the injection technique and what the pen feels like to use, the Mounjaro jab guide covers that in detail.

If you want to understand what a Mounjaro jag involves before you commit to treatment, that page walks through the process from start to finish. Understanding what makes this jag different matters before you start, not as a sales point, but because it sets realistic expectations about why your prescriber might recommend it over another option, and what the titration schedule is actually for.

What the titration schedule is actually doing, and why the first jag isn't the full dose

A question that causes genuine confusion: people receive their first jag at 2.5 mg and assume the medicine is not working because nothing dramatic happens. The 2.5 mg starting dose exists to help your body adjust to the medicine, not to produce therapeutic weight loss. Nausea and other gastrointestinal effects are most likely to surface at the beginning of treatment or after each dose increase. Starting low and moving gradually (typically in four-week steps) reduces how disruptive those early side effects are.

The 5 mg dose is usually the first increase, and the prescriber decides the pace based on how well you are tolerating each level. Some people find 7.5 mg is where appetite suppression becomes clearly noticeable. Others reach the higher strengths before the effect feels significant. The SmPC published on the eMC contains the full prescribing schedule; your prescriber and the patient information leaflet are the right sources for guidance on your individual titration, not forums or social media posts.

One practical note: orders placed by 12 pm on a working day are dispatched the same day once approved, but if you're timing a dose increase around a holiday week or payday, it's worth factoring in bank holidays when DPD's next-working-day delivery runs. Plan a couple of days ahead rather than cutting it close.

Common side effects across the titration period are led by the gut: nausea, loose stools, constipation, indigestion and occasionally burping are the most frequently reported. They tend to ease as your body adapts. The tirzepatide overview page covers side effects in more depth, including when symptoms need medical attention.

Who the Mounjaro jag is licensed for in the UK, and what the eligibility assessment covers

The UK licence covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, dyslipidaemia or obstructive sleep apnoea. Lower BMI thresholds apply for people from some ethnic backgrounds under UK clinical guidance. BMI alone does not determine suitability; a prescriber looks at your full health picture, current medicines and medical history before approving treatment.

NICE recommended tirzepatide for NHS use in December 2024 (TA1026), though NHS access is currently phased and criteria are stricter than the licensed range. Most people accessing Mounjaro jags privately will not meet the current NHS eligibility bands, which is where regulated online pharmacies come in as a legal alternative route. It is also worth reading what to expect on the weight-loss treatment overview before your consultation.

Mounjaro is not recommended during pregnancy, while breastfeeding or when actively trying to conceive. People under 18 are outside the licensed age range. A history of certain conditions (including medullary thyroid carcinoma or pancreatitis) requires careful prescriber discussion, and the MHRA's NHS tirzepatide guidance explains why. Your prescriber will ask about all of this during your assessment. If you have questions about whether this applies to you, the FAQs page addresses some of the more common scenarios.

Getting a legitimate Mounjaro jag safely in the UK

The only legal route to Mounjaro is a prescription following a proper clinical assessment. The MHRA has warned repeatedly about fake weight-loss pens circulating online and via social media; counterfeit pens have been found to contain insulin, with serious consequences for some people who bought them. Sellers offering these jags without a clinical assessment, or at prices dramatically below the market rate, are a significant red flag. The MHRA's Yellow Card service lets you report suspected sellers as well as side effects.

Any legitimate online pharmacy can be verified on the GPhC register at pharmacyregulation.org/registers. At nume, consultations are reviewed by a GPhC-registered Independent Prescriber, a real clinician reads your answers, not automated software. If you are thinking about the cost of private treatment, the Mounjaro cost guide gives an honest breakdown of what is actually included in a private price and what questions to ask any provider. Once approved, treatment is dispatched the same day and arrives the next working day via tracked DPD delivery, in plain packaging.

If you are ready to find out whether Mounjaro is clinically suitable for you, start your free consultation and our prescribers will review it the same day.